SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as it unveils new AI chips targeting the data center market, aiming to compete with Nvidia and AMD. The community is discussing the potential impact of this move on the semiconductor landscape, with some anticipating significant growth for Qualcomm while others suggest increased competition may signal a sector cooldown. Bullish sentiment appears to be fueled by raised price targets and anticipation of a breakthrough in the AI chip world.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the OG meme coin, emphasizing its cultural significance and a return to the 'trenches' of meme creation. Community members express strong conviction and belief in the project, highlighting its organic growth and potential to disrupt the industry. The focus remains on community, memes, and shared enthusiasm.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending amid discussions about a potential acquisition of Larvotto Resources and its impact on the company's valuation. The community is weighing the potential benefits of the deal against concerns about share dilution, while also debating the significance of U.S.-China trade relations and antimony's role as a critical mineral independent of rare earth dynamics.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia is trending downwards following a self-imposed pause in late-stage clinical trials due to liver enzyme elevations in a patient, sparking community debate about the severity and implications of the event. Some investors view the dip as a buying opportunity, citing the potential for trial resumption and the company's long-term prospects in gene editing, while others are concerned about the potential impact on the company's future.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending as chatter revolves around a Trump Jr.-linked drone company securing a Pentagon contract and community members are actively discussing the implications of this contract, along with future targets based on chart analysis. Some traders are speculating on the potential for further government contracts and the overall heating up of the drone sector, while others point to the company's connection to the Trump family as a source of both opportunity and concern. Community members are closely watching for news and volume expansion that could force chasers through resistance levels.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels ($UUUU) is trending as investors weigh the impact of potential US-China trade negotiations on rare earth elements and uranium. Community discussions revolve around large call option sweeps, a possible government stake, and the company's diversified capabilities. Recent news, including a joint venture in Australia, has also fueled speculation about the stock's near-term direction.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending due to its upcoming PDUFA date for Revuforj, with community members weighing in on the potential FDA decision and its impact on the stock. Discussions include the drug's market potential, comparisons to competitor KURA, and speculation about a potential buyout. Some traders are also highlighting the high short interest and potential for a squeeze.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings (CLIK) is trending as traders discuss its potential for a short squeeze, fueled by strong revenue growth and a small float. Community members are actively speculating on price targets, while also closely watching the stock's consolidation patterns. Some traders are also looking at it as a sympathy play with other HK stocks.

Richtech Robotics, Inc. engages in the development of robotic technologies. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics (RR) is trending right now because of its new partnership with the Vegas Golden Knights and excitement around its upcoming humanoid robot reveal at the NVIDIA GTC conference. People are talking about how this could be a big step forward for AI and robotics. Some investors think the company could grow a lot in the future, while others are cautious because the stock might be unstable in the short term.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders weigh the potential for continued gains in the semiconductor sector against concerns of overvaluation and geopolitical risks. Community members are actively discussing entry and exit points, with some anticipating a pullback while others remain bullish, citing strong demand and potential benefits from AI-related developments. News around trade tensions, earnings reports from key semiconductor companies, and broader market sentiment are also influencing the conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Seelos Announces Second Postponement of its Annual Meeting of Stockholders

Seelos Announces Second Postponement of its Annual Meeting of Stockholders Seelos Announces Second Postponement of its Annual Meeting of Stockholders PR Newswire NEW YORK, Oct. 24, 2024 NEW YORK...

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing...

Seelos Announces Postponement of its Annual Meeting of Stockholders

Seelos Announces Postponement of its Annual Meeting of Stockholders Seelos Announces Postponement of its Annual Meeting of Stockholders PR Newswire NEW YORK, Sept. 26, 2024 NEW YORK, Sept. 26, 2024...

Seelos Therapeutics Announces 1-for-16 Reverse Stock Split

Seelos Therapeutics Announces 1-for-16 Reverse Stock Split Seelos Therapeutics Announces 1-for-16 Reverse Stock Split PR Newswire NEW YORK, Sept. 25, 2024 NEW YORK, Sept. 25, 2024 /PRNewswire...

What's Going On With Seelos Therapeutics Stock Tuesday?

Seelos shares are trading higher Tuesday after the company announced that it signed a material transfer agreement to supply SLS-002 for the Department of Defense's Military and Veterans Adaptative...

Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD

Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD Seelos Therapeutics...

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules Seelos Therapeutics Announces Pricing of $1.1...

Seelos Therapeutics Announces 1-for-8 Reverse Stock Split

Seelos Therapeutics Announces 1-for-8 Reverse Stock Split Seelos Therapeutics Announces 1-for-8 Reverse Stock Split PR Newswire NEW YORK, May 14, 2024 NEW YORK, May 14, 2024 /PRNewswire/ -- Seelos...

Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations

Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations Seelos Therapeutics Announces...

Seelos Therapeutics provides update on top-line data of Phase 2/3 trial

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.

Seelos Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

SEEL
Seelos Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SEEL News

SEELSeelos Therapeutics Inc